Esproquin is an α2-adrenergic receptor agonist derived from tetrahydroisoquinoline.

[1] It has a positive inotropic effect, suggesting potential use in treatment of chronic heart failure.

[2] This drug article relating to the cardiovascular system is a stub.

You can help Wikipedia by expanding it.